Skip to main content

Pacira BioSciences, Inc.

PCRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001396814

In the last 90 days, Pacira BioSciences, Inc. insiders filed 0 open-market purchases and 1 sale; 254 institutions reported holding it in 13F filings for Q2 2026, worth $1.11B in total; no superinvestor holds it.

Q2 2024 vs. Q1 2024

How the institutions holding Pacira BioSciences, Inc. changed between Q1 2024 and Q2 2024.

All holders in Q2 2024All holders in Q1 2024

13F holders of PCRX: Q1 2024 compared with Q2 2024
MeasureQ1 2024Of which not filed for Q2 2024Q2 2024Change
Holders2712282+13
Shares49.2M76.6K51.9M+2.79M (+5.7%)
Value$1.44B$2.24M$1.48B+$49.4M (+3.4%)

2 institutions that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (51)

Institutions that held Pacira BioSciences, Inc. at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to PCRX in Q2 2024
InstitutionSharesValue% of portfolio
Fort Washington Investment Advisors Inc462,768$13.2M0.09%
Thornburg Investment Management Inc188,590$5.40M0.08%
Brandywine Global Investment Management, LLC178,396$5.10M0.04%
Lisanti Capital Growth, LLC138,830$3.97M0.95%
Banco Santander, S.A.138,373$3.96M0.05%
Portolan Capital Management, LLC131,901$3.77M0.31%
Qube Research & Technologies Ltd129,191$3.70M0.01%
Winton Group Ltd95,266$2.73M0.18%
Kettle Hill Capital Management, LLC77,598$2.22M0.56%
Villanova Investment Management Co LLC63,351$1.81M1.92%
Arrowstreet Capital, Limited Partnership53,409$1.53M0.00%
Monashee Investment Management LLC40,000$1.14M0.15%
Hennion & Walsh Asset Management, Inc.35,450$1.01M0.05%
Corebridge Financial, Inc.26,612$761.4K0.00%
Mirae Asset Global ETFs Holdings Ltd.22,778$651.7K0.00%
Toroso Investments, LLC21,845$625.0K0.01%
Deerfield Management Company, L.P. (Series C)17,062$488.1K0.01%
Guggenheim Capital LLC16,855$482.2K0.00%
Sherbrooke Park Advisers LLC16,337$467.4K0.08%
LSV Asset Management16,133$462.0K0.00%
Mattson Financial Services, LLC15,786$451.6K0.16%
Truist Financial Corp14,798$423.4K0.00%
Retirement Planning Co of New England, Inc.10,370$296.7K0.16%
RSM US Wealth Management LLC10,402$296.0K0.00%
Brown Financial Advisors10,323$295.3K0.13%
Franklin Resources Inc9,258$264.9K0.00%
MML Investors Services, LLC8,281$237.0K0.00%
Creative Planning8,274$236.7K0.00%
Riverwater Partners LLC7,765$222.2K0.16%
First National Bank of Omaha7,608$217.7K0.01%
LPL Financial LLC7,464$213.5K0.00%
Rafferty Asset Management, LLC7,424$212.4K0.00%
Amundi6,972$151.0K0.00%
Canada Pension Plan Investment Board4,900$140.2K0.00%
Central Pacific Bank - Trust Division4,268$122.1K0.01%
Quest Partners LLC3,961$113.3K0.02%
Innealta Capital, LLC1,749$50.0K0.02%
Park Place Capital Corp1,600$45.8K0.01%
1620 Investment Advisors, Inc.588$16.8K0.01%
Raleigh Capital Management Inc.537$15.4K0.01%
Smartleaf Asset Management LLC267$7.45K0.00%
Quarry LP252$7.21K0.00%
Catalyst Funds Management Pty Ltd200$5.72K0.00%
Coppell Advisory Solutions LLC58$1.66K0.00%
Stephens Consulting, LLC49$1.40K0.00%
SRS Capital Advisors, Inc.42$1.20K0.00%
Ronald Blue Trust, Inc.33$9640.00%
SWAN Capital LLC27$7720.00%
Triad Wealth Partners, LLC27$7720.00%
Larson Financial Group LLC5$1430.00%
Capital Advisors, Ltd. LLC10$00.00%

Sold out (38)

Institutions that held Pacira BioSciences, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.

Institutions that sold out of PCRX in Q2 2024
InstitutionShares, Q1 2024Value, Q1 2024
Clearbridge Investments, LLC1,172,150$34.3M
Archon Capital Management LLC536,525$15.7M
Candriam Luxembourg S.C.A.181,901$5.32M
Neumeier Poma Investment Counsel LLC151,810$4.44M
Clearline Capital LP136,658$3.99M
Cubist Systematic Strategies, LLC134,282$3.92M
Prosight Management, LP94,362$2.76M
Caption Management, LLC48,598$1.42M
Texas Permanent School Fund40,642$1.19M
Millennium Management LLC37,448$1.09M
Duality Advisers, LP34,784$1.02M
Raymond James & Associates30,175$881.7K
ExodusPoint Capital Management, LP26,643$779.0K
American International Group, Inc.24,605$719.0K
Tudor Investment Corp Et Al23,244$679.2K
Gsa Capital Partners LLP22,722$664.0K
Tejara Capital Ltd20,000$584.4K
New York Life Investment Management LLC12,507$365.5K
Azzad Asset Management Inc9,384$274.2K
Dana Investment Advisors, Inc.9,345$273.1K
Brevan Howard Capital Management LP7,395$216.1K
Dynamic Technology Lab Private Ltd7,172$209.0K
Paloma Partners Management Co7,151$209.0K
Stephens Inc4,940$144.3K
Quantbot Technologies LP4,892$142.9K
Point72 Asia (Singapore) Pte. Ltd.3,987$116.5K
Metropolitan Life Insurance Co2,422$70.8K
Simplex Trading, LLC2,281$66.0K
Walleye Capital LLC2,179$63.7K
Apollo Management Holdings, L.P.2,114$61.8K
Headlands Technologies LLC463$13.5K
Parallel Advisors, LLC223$6.52K
Orion Capital Management LLC200$5.84K
Harbor Investment Advisory, LLC38$1.11K
CoreCap Advisors, LLC16$468
Nelson, Van Denburg & Campbell Wealth Management Group, LLC9$262
Elequin Capital LP7$205
Northwestern Mutual Wealth Management Co1$29

Not filed for Q2 2024 yet (2)

Institutions that held Pacira BioSciences, Inc. at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding PCRX in Q1 2024 that haven't filed for Q2 2024
InstitutionShares, Q1 2024Value, Q1 2024
Credit Suisse AG74,728$2.18M
Shell Asset Management Co1,858$53.0K